The last day of 2020 marked a milestone in the research and development of inactivated vaccines to fight COVID-19 in China.At a December 31 press conference organized by the State Council Joint Prevention and Control ...The last day of 2020 marked a milestone in the research and development of inactivated vaccines to fight COVID-19 in China.At a December 31 press conference organized by the State Council Joint Prevention and Control Mechanism Against COVID-19,the National Medical Products Administration announced that it granted conditional emergency usage authorization for an inactivated vaccine for COVID-19 developed by Beijing Institute of Biological Products Co.,Ltd.(BJIBP),a subsidiary of China National Biotec Group(CNBG)under China National Pharmaceutical Group(Sinopharm).It was the first COVID-19 vaccine authorized for emergency use in China.展开更多
A novel method, named critical-network-based (CNB), for timing optimization in global routing is presented in this paper. The essence of this method is different from that of the typical existing ones, named nets-base...A novel method, named critical-network-based (CNB), for timing optimization in global routing is presented in this paper. The essence of this method is different from that of the typical existing ones, named nets-based (NB) and critical-path-based (CPB). The main contribution of this paper is that the CNB delay reduction method is more efficient than the typical existing ones. This new method makes it possible to reduce the delay in an overall survey.Based on CNB, a timing optimization algorithm for global routing is implemented and tested on Microelectronics Center of North Carolina (MCNC) benchmarks in this paper. The experimental results are compared between this algorithm and the existing ones. The experimental results show that this algorithm is able to control the delay efficiently.展开更多
文摘The last day of 2020 marked a milestone in the research and development of inactivated vaccines to fight COVID-19 in China.At a December 31 press conference organized by the State Council Joint Prevention and Control Mechanism Against COVID-19,the National Medical Products Administration announced that it granted conditional emergency usage authorization for an inactivated vaccine for COVID-19 developed by Beijing Institute of Biological Products Co.,Ltd.(BJIBP),a subsidiary of China National Biotec Group(CNBG)under China National Pharmaceutical Group(Sinopharm).It was the first COVID-19 vaccine authorized for emergency use in China.
文摘A novel method, named critical-network-based (CNB), for timing optimization in global routing is presented in this paper. The essence of this method is different from that of the typical existing ones, named nets-based (NB) and critical-path-based (CPB). The main contribution of this paper is that the CNB delay reduction method is more efficient than the typical existing ones. This new method makes it possible to reduce the delay in an overall survey.Based on CNB, a timing optimization algorithm for global routing is implemented and tested on Microelectronics Center of North Carolina (MCNC) benchmarks in this paper. The experimental results are compared between this algorithm and the existing ones. The experimental results show that this algorithm is able to control the delay efficiently.
